<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Phys.org: Phys.Org news tagged with: acute liver failure</title>
<link>http://phys.org/</link>
<language>en-us</language> 
<description>Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Potent human toxins prevalent in Canada's freshwaters</title>
   	 <description>Nutrient pollution, one of the greatest threats to our freshwater resources, is responsible for the algal blooms that blanket our lakes and waterways in summer months. Large blooms of cyanobacteria ('blue green algae') can cause fish kills, increase the cost of drinking water treatment, devalue shoreline properties, and pose health risks to people, pets, and wildlife. A new paper just published in the Canadian Journal of Fisheries and Aquatic Sciences shows that microcystin, a toxin produced by cyanobacteria, is present in Canadian lakes in every province.</description>
     <link>http://phys.org/news264143255.html</link>
	 <category>Space &amp; Earth</category>
	 <pubDate>Tue, 14 Aug 2012 06:08:37 EST</pubDate>
	 <guid isPermaLink="false">news264143255</guid>
	 
</item>
<item>
     <title>Scientists grow human liver tissue to be used for transplantation</title>
   	 <description>A new study reports on the success of growing human liver cells on resorbable scaffolds made from material similar to surgical sutures. Researchers suggest that this liver tissue could be used in place of donor organs during liver transplantation or during the bridge period until a suitable donor is available for patients with acute liver failure. Findings of this study appear in the February issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.</description>
     <link>http://phys.org/news214746473.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 20 Jan 2011 11:48:14 EST</pubDate>
	 <guid isPermaLink="false">news214746473</guid>
	 
</item>
<item>
     <title>Study finds anti-microbials a common cause of drug-induced liver injury and failure</title>
   	 <description>New research shows that anti-microbial medications are a common cause of drug-induced liver injury (DILI) leading to acute liver failure (ALF), with women and minorities disproportionately affected. While ALF evolves slowly, once it does occur a spontaneous recovery is unlikely; however liver transplantation offers an excellent survival rate. Full findings of this ten-year prospective study are published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.</description>
     <link>http://phys.org/news210345029.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 30 Nov 2010 13:40:01 EST</pubDate>
	 <guid isPermaLink="false">news210345029</guid>
	 
</item>
<item>
     <title>Japanese researchers report on liver transplantation studies using animal and iPS cells</title>
   	 <description>Two research teams from the Okayama University Graduate School of Medicine (Okayama, Japan) have reported breakthrough studies in liver cell transplantation. One team found that the technical breakthrough in creating induced pluripotent stem cells (iPS) from mouse somatic cells (nonsex cells) in vitro had &quot;implications for overcoming immunological rejection.&quot; Whereas a second team using liver cell xenotransplantation - transplanting cells of one species into another (in this case transplanting pig liver cells into mice) - found that transplanted liver cells from widely divergent species can function to correct acute liver failure and prolong survival.</description>
     <link>http://phys.org/news206636235.html</link>
	 <category>Biology</category>
	 <pubDate>Mon, 18 Oct 2010 15:57:26 EST</pubDate>
	 <guid isPermaLink="false">news206636235</guid>
	 
</item>
<item>
     <title>Freshwater toxins to blame for sea otter deaths</title>
   	 <description>A potent toxin produced by bright-green blooms of freshwater bacteria has been flowing into the ocean and poisoning sea otters, according to a team of investigators led by scientists at the California Department of Fish and Game (DFG) and the University of California, Santa Cruz. </description>
     <link>http://phys.org/news203595019.html</link>
	 <category>Space &amp; Earth</category>
	 <pubDate>Mon, 13 Sep 2010 11:10:37 EST</pubDate>
	 <guid isPermaLink="false">news203595019</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/freshwaterto.jpg" width="90" height="90" />
</item>
<item>
     <title>Molecular adsorbent recirculating system treatment for acute liver failure</title>
   	 <description>The molecular adsorbent recirculating system (MARS) is used in the treatment of liver failure patients to enable either native liver recovery or as a bridging treatment to liver transplantation. A recent study from Finland suggests that MARS treatment is both less costly and more effective than standard medical therapy in acute liver failure patients.</description>
     <link>http://phys.org/news192876736.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 12 May 2010 10:10:04 EST</pubDate>
	 <guid isPermaLink="false">news192876736</guid>
	 
</item>
<item>
     <title>Beyond liver transplants: Acutely damaged livers may be repaired via transplanted hepatocytes</title>
   	 <description>A research team from the National Taiwan University Hospital has evaluated the efficiency of transplanted hepatocyte (liver) cells in animal models severely damaged by two kinds of chemical toxicity to see whether and how transplanted hepatocytes were able to efficiently repopulate the toxin-induced, severely damaged livers.</description>
     <link>http://phys.org/news184254407.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 01 Feb 2010 15:20:01 EST</pubDate>
	 <guid isPermaLink="false">news184254407</guid>
	 
</item>
<item>
     <title>Medication effective for acute liver failure in early stages of disease</title>
   	 <description>The antidote for acute liver failure caused by acetaminophen poisoning also can treat acute liver failure due to most other causes if given before severe injury occurs, UT Southwestern Medical Center researchers and their colleagues at 21 other institutions have found.</description>
     <link>http://phys.org/news174197254.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 08 Oct 2009 05:07:56 EST</pubDate>
	 <guid isPermaLink="false">news174197254</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/medicationef.jpg" width="90" height="59" />
</item>
<item>
     <title>Is molecular adsorbent recirculating system effective for all the liver failure patients?</title>
   	 <description>Since its introduction in 1993, molecular adsorbent recirculating system (MARS) albumin dialysis has been a subject of research, with the hope of treating effectively patients with acute liver failure. The impact of MARS treatment on outcome as well as clinical and laboratory variables has been investigated widely in small non-randomized studies. However, larger studies with longer follow-up time are required to determine the true usefulness of MARS treatment in different liver failure etiologies.</description>
     <link>http://phys.org/news166271522.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 08 Jul 2009 11:32:27 EST</pubDate>
	 <guid isPermaLink="false">news166271522</guid>
	 
</item>
<item>
     <title>Study examines liver transplantation after drug induced acute liver failure</title>
   	 <description>Liver transplantation offers a good chance for survival for patients with drug induced acute liver failure, however, certain pre-transplant factors are associated with worse outcomes. Patients who are on life support, who have elevated serum creatinine, and children whose liver failure was caused by antiepileptic drugs did not fare as well after transplantation. These findings are in the July issue of Liver Transplantation, a journal published by John Wiley &amp; Sons.</description>
     <link>http://phys.org/news165675234.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 01 Jul 2009 13:55:35 EST</pubDate>
	 <guid isPermaLink="false">news165675234</guid>
	 
</item>


</channel>
</rss>
